Skip to main navigation Skip to search Skip to main content

Long-Term Azithromycin Maintenance Treatment in Patients with Frequent Exacerbations of Chronic Obstructive Pulmonary Disease

  • External organisation

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Scopus)

Abstract

Macrolides are effective in reducing the number of exacerbations in COPD patients with the frequent exacerbator phenotype. Our study did not show a persistent effect of azithromycin on exacerbation frequencies after more than one year of usage.

Original languageEnglish
Pages (from-to)495-498
Number of pages4
JournalThe International Journal of Chronic Obstructive Pulmonary Disease
Volume16
DOIs
Publication statusPublished - 1 Mar 2021

Bibliographical note

Publisher Copyright:
© 2021 Talman et al.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research programs

  • EMC OR-01

Fingerprint

Dive into the research topics of 'Long-Term Azithromycin Maintenance Treatment in Patients with Frequent Exacerbations of Chronic Obstructive Pulmonary Disease'. Together they form a unique fingerprint.

Cite this